epithelial-to-mesenchymal transition

You have access
Development of a Benzoxazine-derived Inhibitor Targeting Epithelial-to-Mesenchymal Transition in Lung Cancer
NAPHATSON PHANSOM, ZIN ZIN EI, BHURICHAYA INNETS, WORAWAT WATTANATHANA, THEERA RITTIROD, ACHARAWAN THONGMEE, KEERATI JOYJAMRAS and PITHI CHANVORACHOTE

Anticancer Research July 2025, 45 (7) 2807-2815; DOI: https://doi.org/10.21873/anticanres.17649
You have access
Inhibition of Epithelial–Mesenchymal Transition and Migration in Cisplatin-resistant Cancer Through Combined Treatment With Cisplatin and SH003
HYEONG SIM CHOI, JEONG-KUI KU, SEONG-GYU KO and PIL-YOUNG YUN

Anticancer Research October 2024, 44 (10) 4359-4369; DOI: https://doi.org/10.21873/anticanres.17265
Open Access
Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality
SETH BURYSKA, KETAN PATEL, BEVERLY WUERTZ, PATRICK M. GAFFNEY and FRANK ONDREY

Anticancer Research December 2023, 43 (12) 5299-5310; DOI: https://doi.org/10.21873/anticanres.16733
You have access
Intracellular C3 Modulates EMT via the Akt/Smad Pathway in Pancreatic Cancer Cells
REI SUZUKI, TADAYUKI TAKAGI, MITSURU SUGIMOTO, YUKI SATO, HIROKI IRIE, YUKI YOMOGIDA and HIROMASA OHIRA

Anticancer Research December 2022, 42 (12) 5743-5750; DOI: https://doi.org/10.21873/anticanres.16081
You have access
15-Prostaglandin Dehydrogenase Inhibition Enhances Colon Cancer Metastasis by Up-regulation of Epithelial-to-Mesenchymal Transition Genes
SUN-HEE KIM, SEONG EUN SONG, HYUNGJOO BAIK, DAE YOUNG HUR, MI SEON KANG and KI BEOM BAE

Anticancer Research November 2022, 42 (11) 5385-5396; DOI: https://doi.org/10.21873/anticanres.16043
You have access
STAT3 Inactivation and Induction of Apoptosis Associate With Fluoxetine-inhibited Epithelial-mesenchymal Transition and Growth of Triple-negative Breast Cancer In Vivo
PEN-AN LIAO, PEI-YI CHU, ZHAO-LIN TAN, FEI-TING HSU, YANG-CHENG LEE and HSING-JU WU

Anticancer Research August 2022, 42 (8) 3807-3814; DOI: https://doi.org/10.21873/anticanres.15871
You have access
The Complement C3a–C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma
REI SUZUKI, YOSHINORI OKUBO, TADAYUKI TAKAGI, MITSURU SUGIMOTO, YUKI SATO, HIROKI IRIE, JUN NAKAMURA, MIKA TAKASUMI, TSUNETAKA KATO, MINAMI HASHIMOTO, RYOUICHIRO KOBASHI, TAKUTO HIKICHI and HIROMASA OHIRA

Anticancer Research March 2022, 42 (3) 1207-1215; DOI: https://doi.org/10.21873/anticanres.15587
You have access
Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-β/Smad/miR-181b/TIMP3 Signaling Pathway
CHIA-HERNG YUE, CHUNG-HUNG CHEN, YING-RU PAN, YI-PING CHEN, FU-MEI HUANG and CHIA-JEN LEE

Anticancer Research December 2021, 41 (12) 6095-6104; DOI: https://doi.org/10.21873/anticanres.15429
You have access
Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway
TSAI-KUN WU, YEN-CHUAN OU, YI-PING CHEN, FU-MEI HUANG, YING-RU PAN and CHIA-JEN LEE

Anticancer Research August 2021, 41 (8) 3789-3799; DOI: https://doi.org/10.21873/anticanres.15171
You have access
SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2
KAYLA L. STEED, HARRISON R. JORDAN and TRYGVE O. TOLLEFSBOL

Anticancer Research January 2020, 40 (1) 9-26; DOI: https://doi.org/10.21873/anticanres.13922

Main menu

User menu

Search

epithelial-to-mesenchymal transition

Pages